Beta carotene, Vitamin E, and lung cancer

Paul R. Marantz, David Kritchevsky, Mark R. Goldstein, William A. Pryor, Maria A. Leo, Charles S. Lieber, Peter E. Ballmer, Hannes B. Stahelin, Olli P. Heinonen, Jussi K. Huttunen, Demetrius Albanes, Philip R. Taylor, Charles H. Hennekens, Julie E. Buring, Richard Peto

Research output: Contribution to journalLetter

9 Scopus citations

Abstract

To the Editor: The controversy in the lay press after the publication of the findings of the Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (April 14 issue)1 was understandable. Clearly, the public was confused by yet another unfulfilled promise of longevity, and both faddists and manufacturers of vitamin supplements found these results inconsistent with their own beliefs, which had been supported by observational data. What was not comprehensible, and was quite disturbing, was the irresolute manner in which the findings of the study were interpreted by its authors and those of the accompanying editorial2. The authors concluded that no.

Original languageEnglish (US)
Pages (from-to)611-614
Number of pages4
JournalNew England Journal of Medicine
Volume331
Issue number9
DOIs
StatePublished - Sep 1 1994

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Beta carotene, Vitamin E, and lung cancer'. Together they form a unique fingerprint.

  • Cite this

    Marantz, P. R., Kritchevsky, D., Goldstein, M. R., Pryor, W. A., Leo, M. A., Lieber, C. S., Ballmer, P. E., Stahelin, H. B., Heinonen, O. P., Huttunen, J. K., Albanes, D., Taylor, P. R., Hennekens, C. H., Buring, J. E., & Peto, R. (1994). Beta carotene, Vitamin E, and lung cancer. New England Journal of Medicine, 331(9), 611-614. https://doi.org/10.1056/NEJM199409013310912